
Health PR firm Say Communications has announced the appointment of Victoria Bramham as an associate director to help lead its …

GlaxoSmithKline has put in supplemental applications for its Tafinlar/Mekinist combination – a pair of drugs which analysts predict may have …

One of Novartis’ investigational drugs has beaten Pfizer’s Enbrel in a head-to-head Phase III psoriasis study and is on course …

GlaxoSmithKline has announced a partnership with a UK biotech firm to develop oncology medicines using new methods to fight the …

For the first time, three pharmaceutical compounds – two hormones and an anti-inflammatory drug – will be included in a …
A new review is inviting pharma to tell the UK government just how well national regulators and local authorities enforce …

Healthcare management firm Continuum Health Alliance has appointed Christopher Olivia to be the president of the company.Dr Olivia will help lead Continuum into …

Merck Sharp & Dohme has been censured by the PMCPA for failing to uphold standards in the way it promoted …

GlaxoSmithKline’s woes in China are continuing as the firm’s sales tactics with Botox are put under scrutiny. The London-based firm …

The government has invested £100 million into a new DNA mapping service for patients, and will begin with cancer, rare …

Novartis’ breast cancer drug Afinitor (everolimus) has been knocked back by NICE as “it is not good value for money”. …

My name is Ben Adams, and I have the honour and the responsibility of becoming the new editor at Pharmafocus.I …

Creative comms agency Life Healthcare Communications is developing its client services team further with the appointment of a new senior account …

Directors responsible for failures in care such as those seen at the Mid Staffordshire NHS Foundation Trust should face prosecution, …

Having surgery to treat bowel cancer massively increases a patient’s chance of survival, according to data from a new national …

The Department of Health has announced the appointment of Dr Ian Hudson as chief executive of the Medicines and Healthcare …
A round-up of recent developments in the pharma manufacturing sector, including a fine for King Pharma, a strike at a …

The pharma industry could face a series of lawsuits by manufacturers of promotional gifts as new rules look to ban …

GlaxoSmithKline is being investigated by authorities in China in what appear to be two separate probes into the UK manufacturer’s …

Pharma companies in Europe will have to reveal how much they pay to doctors under a voluntary agreement set out …